We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Nanotechnology Advance Enables High-Resolution Structural Studies of Membrane Proteins

By LabMedica International staff writers
Posted on 23 Mar 2016
A novel nanotechnology advance in the field of protein structural analysis allows for the isolation and reconstitution of membrane proteins in a lipid environment where they can by analyzed in their native state.

Membrane proteins are the targets of more than 60% of drugs in clinical use. More...
However, a limiting factor in membrane protein research is the ability to solubilize and stabilize such proteins. Detergents are used most often for solubilizing membrane proteins, but they are associated with protein instability and poor compatibility with structural and biophysical studies.

Investigators at Karolinska Institutet (Stockholm, Sweden) recently described a saposin-lipoprotein nanoparticle system, which they called Salipro. This system allowed for the reconstitution of membrane proteins in a lipid environment that was stabilized by a scaffold of saposin proteins.

The investigators demonstrated the applicability of the method on two purified membrane protein complexes as well as by the direct solubilization and nanoparticle incorporation of a viral membrane protein complex from the virus membrane. This approach facilitated high-resolution structural studies of the bacterial peptide transporter PeptTSo2 by single-particle cryo-electron microscopy (cryo-EM) and enabled the stabilization of the HIV envelope glycoprotein in a functional state.

Cryo-EM is an analytical technique complementary to NRM and X-ray diffraction crystallography that provides near-atomic resolution without the requirements for crystallization or limits on molecular size and complexity imposed by the other techniques. Cryo-EM allows the observation of specimens that have not been stained or fixed in any way, showing them in their native environment while integrating multiple images to form a three-dimensional model of the sample.

"To our knowledge, the HIV spike protein preparation presented in the study using the Salipro system represents the first approach that allows the stabilization of the HIV-1 spike, including the important membrane domains, in a soluble and functional state", said senior author Dr. Pär Nordlund professor of oncology-pathology at Karolinska Institutet.

The paper describing the Salipro system was published in the March 7, 2016, online edition of the journal Nature Methods.

Related Links:

Karolinska Institutet



Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Homocysteine Quality Control
Liquichek Homocysteine Control
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.